Silk Road Medical Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Silk Road Medical stock.
View analyst ratings for Silk Road Medical or view top-rated stocks.

Wall Street analysts have given Silk Road Medical a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Silk Road Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 9th 2021.
View our earnings forecast for Silk Road Medical.

Silk Road Medical, Inc (NASDAQ:SILK) released its quarterly earnings data on Thursday, July, 29th. The company reported ($0.31) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.37) by $0.06. Silk Road Medical had a negative trailing twelve-month return on equity of 44.13% and a negative net margin of 53.85%.
View Silk Road Medical's earnings history.

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SILK stock has increased by 35.1% and is now trading at $50.18.
View which stocks have been most impacted by COVID-19.

Silk Road Medical issued an update on its FY 2021 earnings guidance on Thursday, July, 29th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $104 million-$109 million, compared to the consensus revenue estimate of $106.04 million.

4 analysts have issued 1 year price targets for Silk Road Medical's stock. Their forecasts range from $55.00 to $75.00. On average, they anticipate Silk Road Medical's stock price to reach $61.00 in the next year. This suggests a possible upside of 21.6% from the stock's current price.
View analysts' price targets for Silk Road Medical or view top-rated stocks among Wall Street analysts.

Some companies that are related to Silk Road Medical include Tandem Diabetes Care (TNDM), ShockWave Medical (SWAV), Integra LifeSciences (IART), Nevro (NVRO), Inspire Medical Systems (INSP), Inari Medical (NARI), ICU Medical (ICUI), Merit Medical Systems (MMSI), AtriCure (ATRC), NuVasive (NUVA), Haemonetics (HAE), Axonics (AXNX), Glaukos (GKOS), The Beauty Health (SKIN) and Inovio Pharmaceuticals (INO).
View all of SILK's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), The Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), Honeywell International (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Silk Road Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Alliancebernstein L.P. (6.97%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Pincus & Co Warburg and Richard Ruedy.
View institutional ownership trends for Silk Road Medical.

SILK stock was purchased by a variety of institutional investors in the last quarter, including Alliancebernstein L.P..
View insider buying and selling activity for Silk Road Medical or or view top insider-buying stocks.

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SILK stock can currently be purchased for approximately $50.18.

Silk Road Medical has a market capitalization of $1.73 billion and generates $75.23 million in revenue each year. The company earns $-47,370,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

Silk Road Medical employs 281 workers across the globe.

The official website for Silk Road Medical is www.silkroadmed.com.

Silk Road Medical is headquartered at 1213 INNSBRUCK DR., SUNNYVALE CA, 94089.

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]